Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Eur J Pharmacol ; 818: 300-305, 2018 Jan 05.
Article de Anglais | MEDLINE | ID: mdl-29106903

RÉSUMÉ

This study investigated whether crocin exerted neuroprotective effects against acute hypobaric hypoxia at high altitude in vivo and determined the underlying mechanisms. Male Sprague-Dawley rats were randomly assigned to a normoxic group,a hypoxic group, and three crocin groups at three different doses. The rats were transferred from 50m to 4200m for 3 days after treatment with crocin for 3 days. The learning and memory of the rat were evaluated with the Morris water maze test. Transmission electron microscope (TEM) was used to analyze the changes in the ultrastructure of hippocampal neurons. Peroxisome proliferator-activated receptor-γ co-activator 1α (PGC-1α) and sirtuin-1 (SIRT1) levels were determined using immunohistochemical staining and western blotting. The escape latency of the crocin group was shorter than that of the hypoxic group, while the frequency of the rats reaching the platform was significantly higher in the crocin group. The structures of nerve cells and mitochondria were destroyed in the hypoxic group, but were repaired in the crocin groups. The expressions of PGC-1α and SIRT1 were decreased in the hypoxic group, but were increased in the crocin group. All the effects improved by crocin were dose-dependent. Crocin attenuates acute hypobaric hypoxia-induced cognitive deficits in rats, accompanied by repairing the structures of hippocampal neurons and improving PGC-1α and SIRT1 levels.


Sujet(s)
Caroténoïdes/pharmacologie , Troubles de la cognition/complications , Troubles de la cognition/traitement médicamenteux , Hypoxie/complications , Maladie aigüe , Animaux , Caroténoïdes/usage thérapeutique , Troubles de la cognition/anatomopathologie , Troubles de la cognition/physiopathologie , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Hippocampe/anatomopathologie , Hippocampe/physiopathologie , Mâle , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Neurones/effets des médicaments et des substances chimiques , Neurones/métabolisme , Neurones/ultrastructure , Coactivateur 1-alpha du récepteur gamma activé par les proliférateurs de peroxysomes/métabolisme , Transport des protéines/effets des médicaments et des substances chimiques , Rats , Rat Sprague-Dawley , Sirtuine-1/métabolisme
2.
J Biomed Biotechnol ; 2008: 518093, 2008.
Article de Anglais | MEDLINE | ID: mdl-18431451

RÉSUMÉ

Elliptic curve cryptographic algorithms convert input data to unrecognizable encryption and the unrecognizable data back again into its original decrypted form. The security of this form of encryption hinges on the enormous difficulty that is required to solve the elliptic curve discrete logarithm problem (ECDLP), especially over GF(2(n)), n in Z+. This paper describes an effective method to find solutions to the ECDLP by means of a molecular computer. We propose that this research accomplishment would represent a breakthrough for applied biological computation and this paper demonstrates that in principle this is possible. Three DNA-based algorithms: a parallel adder, a parallel multiplier, and a parallel inverse over GF(2(n)) are described. The biological operation time of all of these algorithms is polynomial with respect to n. Considering this analysis, cryptography using a public key might be less secure. In this respect, a principal contribution of this paper is to provide enhanced evidence of the potential of molecular computing to tackle such ambitious computations.


Sujet(s)
Algorithmes , Sécurité informatique , Ordinateurs moléculaires , ADN/composition chimique , ADN/génétique , Mémorisation et recherche des informations/méthodes
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE